United States· US:0781-3481_c5721224-91db-4fe4-b746-139bce5ff19c

Tigecycline

A tigecycline product containing tigecycline, registered in United States by Sandoz Inc. The same ATC class is registered in 17 of our 19 countries.

ATC J01AA12

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTigecyclineATCJ01AA12REGISTER NO.US:0781-3481_c5721224…PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Tigecycline is registered in 17 of 19 countries.

Countries holding a registration under ATC J01AA12 (tigecycline), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Tigecycline · ATC J01AA12

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tigecycline costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tigecycline · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • FI Finland$3.05
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TIGECYCLINE
Manufacturer
Sandoz Inc
Country
United States (US)
ATC code
J01AA12
ATC class
Tigecycline
Defined daily dose
0.1 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    0781-3481-92

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

65 interactions on record for tigecycline.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tigecycline · interactions on record

65 records

  • 3 severe
  • 13 moderate
  • 24 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Sodium picosulfateA06AB08moderate

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tigecycline in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tigecycline products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Tigecyclin Aptapharma, Tigecyclin Hikma
  • Bulgaria · Тигециклин Аптафарма, Тигециклин Ромфарм
  • Cyprus · Tigecycline Aptapharma, Tigecycline Sapiens
  • Czechia · Tigecycline Aptapharma, Tigecycline Mylan
  • Germany · Tigecyclin Amarox, Tigecyclin Carinopharm
  • Denmark · Tigecycline Eql Pharma
  • Estonia · Tigecycline Inteli, Tigecycline Norameda
  • Spain · Tigeciclina Cipla, Tigeciclina Hikma
  • Finland · Tigecycline Eql Pharma, Tigecycline Norameda
  • France · Tigecycline Amarox, Tigecycline Hikma
  • United Kingdom (Northern Ireland) · Tigecycline Aft Pharma Uk, Tigecycline Amarox
  • Greece · Digazor, Tigecycline Anfarm
  • Croatia · Tigeciklin Aptapharma, Tigeciklin Galenika
  • Hungary · Tigeciklin Galenika, Tigeciklin Noridem
  • Ireland · Tigecycline Noridem Enterprises
  • Iceland · Tigecycline Accord, Tygacil
  • Italy · Tigeciclina Amarox, Tigeciclina Cipla
  • Liechtenstein · Tigecycline Accord, Tygacil
  • Lithuania · Tigecycline Inteli, Tigecycline Norameda
  • Latvia · Tigecycline Inteli, Tigecycline Norameda
  • Malta · Tigecycline Anfarm, Tigecycline Aptapharma
  • Netherlands · Tigecycline Amarox, Tigecycline Hikma
  • Norway · Tigecycline Accord, Tigecycline Eql Pharma
  • Poland · Tigecycline Aptapharma, Tigecycline Norameda
  • Portugal · Tigeciclina Cipla, Tigeciclina Hikma
  • Romania · Tigeciclină Aptapharma, Tigeciclina Atb
  • Sweden · Tigecycline Eql Pharma, Tigecycline Viatris
  • Slovenia · Tigeciklin Aptapharma, Tigeciklin Diagonalis
  • Slovakia · Tigecycline Aptapharma, Tigecycline Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/890bc9e6-0929-478a-86f4-9f5995b86625
GET /v1/drugs/890bc9e6-0929-478a-86f4-9f5995b86625?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS; PARENTERAL",
  "source": "ndc",
  "strength": "50",
  "substance": "TIGECYCLINE",
  "productndc": "0781-3481",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/10mL",
  "application_number": "ANDA091620",
  "marketing_category": "ANDA"
}

See everything about tigecycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.